A1 Refereed original research article in a scientific journal

Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland




AuthorsTorkki Paulus, Paajanen Juuso, Kytö Ville, Laaksonen Sanna, Räsänen Jari, Myllärniemi Marjukka, Ilonen Ilkka

Publication year2021

JournalThoracic cancer

Journal name in sourceThoracic cancer

Journal acronymThorac Cancer

Volume12

Issue19

First page 2594

Last page2600

ISSN1759-7706

eISSN1759-7714

DOIhttps://doi.org/10.1111/1759-7714.14146

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/67438237


Abstract

Background
Substantial variation in health care costs for malignant pleural mesothelioma (MPM) has previously been identified.

Materials and Methods
We analyzed the changes in health care costs in MPM in Finland during 2002–2012. Finland has low-threshold public health care and a mandatory Workers' Compensation scheme that covers all occupational-related disease expenses. The costs include treatment costs for inpatients, hospice care, medication costs, rehabilitation costs, and travel costs. All costs are expressed in 2012 prices, adjusted using the consumer price index.

Results
A total of 907 MPM patients were included in the study. Mean duration of inpatient episodes increased 7% per year from 2002 to 2012, correlating with total costs (R2 = 0.861, p < 0.05). The annual total costs for treatment increased from 1.7 to 4.3 m€ during the study period and the cost per patient from 27 000 to 43 000 €. The overall costs increased progressively by the number of procedures performed. In patients who had been compensated for occupational cause by Workers' Compensation Center, only 36% of the overall care costs were billed from the insurance company. Billing of inpatient costs was 86% in these patients.

Conclusion
During the study period, we found that the costs of MPM increased more than the average health care costs. This may be because of advanced diagnostic workup or more costly treatment (e.g., pemetrexed). Moreover, only one-third of all health care costs are charged to Workers' Compensation Insurance.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 21:36